Viridian Therapeutics, Inc.\DE VRDN
NASDAQ VRDN
$20.59 +0.59 (+2.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Viridian Therapeutics, Inc.\DE (VRDN) Total Current Liabilities (2013 - 2026)

Updated

Viridian Therapeutics, Inc.\DE (VRDN) recorded Total Current Liabilities of $63.79 million in Q2 2026, up 21.3% from $52.59 million a year earlier and up 23.1% from the prior quarter.

Analysis

Viridian Therapeutics, Inc.\DE (VRDN) Total Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Viridian Therapeutics, Inc.\DE reported Total Current Liabilities of $70.7 million, up 47.7% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of 46.0% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $47.87 million in FY2024 (+79.7%), $26.64 million in FY2023 (-20.1%), $33.35 million in FY2022 (+144.6%) and $13.64 million in FY2021 (+27.7%).
  • Quarterly Total Current Liabilities has ranged from $13.64 million in Q4 2021 to $70.7 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Total Current Liabilities has increased for nine consecutive quarters, with growth averaging 46.9% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 144.6% in Q4 2022, against a decline of 20.1% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $51.81 million (Q1 2026), $70.7 million (Q4 2025) and $50.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 Viridian Therapeutics, Inc.\DE 2.33 Bn 2.33 Bn - 63.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.79 Mn
Mar 31, 2026 51.81 Mn
Dec 31, 2025 70.70 Mn
Sep 30, 2025 50.70 Mn
Jun 30, 2025 52.59 Mn
Mar 31, 2025 33.73 Mn
Dec 31, 2024 47.87 Mn
Sep 30, 2024 41.36 Mn
Jun 30, 2024 36.76 Mn
Mar 31, 2024 26.13 Mn
Dec 31, 2023 26.64 Mn
Sep 30, 2023 23.25 Mn
Jun 30, 2023 28.66 Mn
Mar 31, 2023 29.59 Mn
Dec 31, 2022 33.35 Mn
Sep 30, 2022 25.21 Mn
Jun 30, 2022 21.39 Mn
Mar 31, 2022 14.39 Mn
Dec 31, 2021 13.64 Mn
Sep 30, 2021 14.34 Mn
API Access

Viridian Therapeutics, Inc.\DE Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VRDN&period=max&api_key=YOUR_API_KEY